Rocket Pharmaceuticals, Inc (RCKT) Covered Calls

You can sell covered calls on Rocket Pharmaceuticals, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for RCKT (prices last updated Wed 4:16 PM ET):

Rocket Pharmaceuticals, Inc (RCKT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
18.26 -1.04 16.44 20.24 287K -7.8 0.9B
Covered Calls For Rocket Pharmaceuticals, Inc (RCKT)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
May 17 17.5 0.75 19.49 -10.2% -155.1%
Jun 21 17.5 1.60 18.64 -6.1% -37.7%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating pediatric diseases. It has two lentiviral vector (LVV) programs under clinical testing to treat fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells; and three LVV programs for the treatment of other rare genetic diseases, as well as an adeno-associated viral vector program, which is under preclinical development. The company has collaboration agreements with Lund University, Sweden; and Centro de Investigaciones Energ√ąticas, Medioambientales y Tecnol√õgicas. The company is headquartered in New York, New York.